Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
Condition(s):Diabetic Nephropathies; Diabetic Kidney DiseaseLast Updated:December 7, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Diabetic Nephropathies; Diabetic Kidney DiseaseLast Updated:December 7, 2020Unknown status
Condition(s):Diabetic NephropathiesLast Updated:April 30, 2021Unknown status
Condition(s):Dementia; Stroke; Cognitive Change; Cerebrovascular; Disorder, ThromboticLast Updated:March 26, 2024Not yet recruiting
Condition(s):PreDiabetes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Body Weight; Body Weight ChangesLast Updated:March 7, 2022Completed
Condition(s):Patient-Controlled AnalgesiaLast Updated:March 25, 2024Recruiting
Condition(s):Diabetes Mellitus; Type 2 Diabetes; ObesityLast Updated:December 8, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 2; ObesityLast Updated:January 20, 2023Withdrawn
Condition(s):Sarcoidosis; Cardiac Sarcoidosis; Boeck’s Disease; Besnier-Boeck DiseaseLast Updated:January 19, 2024Recruiting
Condition(s):Alzheimer Disease; Sleep Initiation and Maintenance DisordersLast Updated:January 13, 2012Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:October 3, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.